MAIA Biotechnology reported net income of -$7.95M for the quarter ended Jun 2026. This income statement covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 1.08M | 1.51M | 2.08M | 2.12M | 2.34M | 2.39M | 2.20M | 2.60M | 2.60M | 3.72M | 2.32M | 2.05M | 2.67M | 2.97M | 3.20M | 3.11M | 6.36M | 1.88M | 3.53M | 5.64M | |
| Selling, General & AdministrativeSG&A | 1.15M | 1.49M | 1.37M | 1.32M | 1.65M | 1.80M | 1.99M | 2.07M | 2.36M | 2.66M | 1.63M | 1.76M | 1.52M | 2.04M | 2.23M | 2.06M | 3.00M | 2.44M | 3.42M | 2.68M | |
| Other Operating ExpensesOther Opex | -2.97M | 0.11M | 0.03M | 0.14M | 0.19M | 0.05M | 0.07M | 0.14M | 0.08M | 0.12M | -4.12M | -5.06M | 1.45M | 1.43M | 0.91M | -0.18M | 0.46M | 0.69M | |||
| Operating ExpensesOpex | 2.23M | 3.00M | 3.44M | 3.44M | 5.10M | 4.20M | 4.18M | 4.66M | 4.96M | 6.38M | 3.95M | 3.82M | 4.19M | 5.00M | 5.43M | 5.17M | 9.36M | 4.32M | 6.95M | 8.32M | |
| Operating IncomeOp. Inc | -2.23M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.18M | -4.66M | -4.96M | -6.38M | -3.95M | -3.82M | -4.19M | -5.00M | -5.43M | -5.17M | -9.36M | -4.32M | -6.95M | -8.32M | |
| EBIT | -2.23M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.18M | -4.66M | -4.96M | -6.38M | -3.95M | -3.82M | -4.19M | -5.00M | -5.43M | -5.17M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Non-operating items | |||||||||||||||||||||
| Non Operating Interest Expenses | 0.45M | 104.00 | 0.00M | 0.01M | 0.01M | 0.00M | 1.00 | 85.00 | -28.00 | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 708.00 | 511.00 | 472.00 | 429.00 | 348.00 | 621.00 | 336.00 | 172.00 | 0.00M | 0.03M | 0.04M | 0.09M | 0.11M | 0.08M | 0.08M | 0.08M | |||||
| Other Non Operating IncomeOther Non Op Inc. | -2.32M | 0.11M | 0.08M | 0.91M | -0.18M | 0.08M | 0.07M | 0.58M | 0.37M | ||||||||||||
| Net income details | |||||||||||||||||||||
| EBT | -2.68M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.19M | -4.67M | -4.95M | -6.35M | -3.90M | -3.73M | -4.08M | -4.92M | -5.34M | -5.09M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Profit After TaxPAT | -5.20M | -2.89M | -3.41M | -3.31M | -4.95M | -4.11M | -4.12M | -4.52M | -4.89M | -6.21M | -8.07M | -8.88M | -2.74M | -3.59M | -4.52M | -5.35M | -8.90M | -3.65M | -6.37M | -7.95M | |
| Income from Non-Controlling InterestsInc. Minority | -0.01M | ||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.68M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.19M | -4.67M | -4.95M | -6.35M | -3.90M | -3.73M | -4.08M | -4.92M | -5.34M | -5.09M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Consolidated Net IncomeConsol Net Inc. | -2.68M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.19M | -4.67M | -4.95M | -6.35M | -3.90M | -3.73M | -4.08M | -4.92M | -5.34M | -5.09M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Income towards Parent CompanyParent Net Inc | -2.68M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.19M | -4.67M | -4.95M | -6.35M | -3.90M | -3.73M | -4.08M | -4.92M | -5.34M | -5.09M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Net Income towards Common StockholdersNet Income | -5.20M | -2.89M | -3.86M | -3.31M | -4.90M | -4.15M | -4.12M | -4.52M | -4.88M | -6.26M | -8.07M | -8.88M | -2.74M | -3.57M | -4.52M | -5.35M | -8.90M | -3.63M | -6.37M | -7.94M | |
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -1.02 | -0.55 | -0.50 | -0.40 | -0.48 | -0.45 | -0.38 | -0.35 | -0.36 | -0.47 | -0.46 | -0.40 | -0.11 | -0.16 | -0.16 | -0.18 | -0.27 | -0.11 | -0.14 | -0.13 | |
| EPS (Diluted) | -1.02 | -0.55 | -0.50 | -0.40 | -0.48 | -0.45 | -0.38 | -0.35 | -0.36 | -0.47 | -0.46 | -0.40 | -0.11 | -0.16 | -0.16 | -0.18 | -0.27 | -0.11 | -0.14 | -0.13 | |
| Shares Outstanding | 5.12M | 5.28M | 7.75M | 8.20M | 10.17M | 9.28M | 10.98M | 12.89M | 13.68M | 13.26M | 17.60M | 22.20M | 23.89M | 22.20M | 27.70M | 30.30M | 33.20M | 32.11M | 45.21M | 60.79M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 5.12M | 5.28M | 7.75M | 8.20M | 10.17M | 9.28M | 10.98M | 12.89M | 13.68M | 13.26M | 17.60M | 22.20M | 23.89M | 22.20M | 27.70M | 30.30M | 33.20M | 32.11M | 45.21M | 60.79M | |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.12M | 5.28M | 7.94M | 8.42M | 10.95M | 10.96M | 11.00M | 13.65M | 13.76M | 13.26M | 20.58M | 23.74M | 23.97M | 26.16M | 29.59M | 31.82M | 34.45M | 32.11M | 45.21M | 60.82M | |
| EBITDA | -2.23M | -3.00M | -3.44M | -3.44M | -5.10M | -4.20M | -4.18M | -4.66M | -4.96M | -6.38M | -3.95M | -3.82M | -4.19M | -5.00M | -5.43M | -5.17M | -9.36M | -4.32M | -6.95M | -8.32M | |
| Interest ExpensesInt Expense | 0.45M | 104.00 | 0.00M | 0.01M | 0.01M | 0.00M | 1.00 | 85.00 | -28.00 |